Table 4.
Most frequent risk of biases | Random sequence generation, allocation concealment, baseline characteristics, baseline outcome measurements similar, and contamination between intervention and comparator |
Study designs | Not restricted to RCTs or cluster RCTs |
Economic quality criteria | Most criteria are met but there are some issues: not detailing target population; not describing “usual care” comparators; not including patient costs, indirect costs or intervention fees; analytical methods poorly described; incremental costs and outcomes sometimes not reported; not accounting for uncertainty |
Heterogeneity | In populations, interventions and some outcomes |
Equity | Not assessed |
Process dimensions | Process dimensions that impact dissemination and external validity poorly described. |
RCT randomized controlled trial